Sinusitis News and Research

Latest Sinusitis News and Research

Study identifies new allergy pathway

Researchers at Johns Hopkins Bloomberg School of Public Health have identified the sequence of molecular events by which tiny, tick-like creatures called house dust mites trigger asthma and allergic rhinitis.

25 Jun 2020

'Good' bacteria have a niche in our noses, study suggests

Beneficial strains of bacteria residing in our guts, genital tracts, and skin have been shown to play a role in human health, and now, researchers publishing May 26 in the journal Cell Reports suggest that some of these "good" bacteria also have a niche in our noses.

26 May 2020

ACTG initiates clinical trial to evaluate treatment for COVID-19

The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).

14 May 2020

Universal childhood vaccination could prevent antimicrobial resistance

A new study from the University of California, Berkeley, published in the journal Nature in April 2020, reports that extending vaccination to all children could help resolve antimicrobial resistance - one of the biggest obstacles to effective healthcare in low-income countries. This is the first study to look at how vaccination is related to the use of antibiotics in low- and middle-income countries.

29 Apr 2020

Intermountain Healthcare and University of Utah Health launch two COVID-19 clinical trials

Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs - hydroxychloroquine and azithromycin - to treat patients with COVID-19.

13 Apr 2020

University of Utah Health, Intermountain Healthcare launch two clinical trials to treat COVID-19 patients

Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs -hydroxychloroquine (HCQ) and azithromycin - to treat patients with COVID-19 (infection with the novel coronavirus).

9 Apr 2020

Novel, affordable pneumonia vaccine tested in human patients

A novel vaccine against pneumonia that is less expensive and more effective than those currently used in Brazil is being tested in human patients.

31 Mar 2020

COVID19 patients describe a loss of smell and taste

Some medical specialists think that the sudden inability to smell or taste familiar odors and flavors could be an early sign of the novel coronavirus infection. This sign could be as innocuous-looking as feeling that food suddenly tastes bland, or that familiar strong smells aren't getting through. Yet, it could signal the need to isolate oneself because it is a little-known yet characteristic sign of COVID-19, the disease caused by the novel coronavirus that is racing around the world.

23 Mar 2020

Blue Water Vaccines enters into agreement to develop Streptococcus pneumoniae vaccine with St. Jude

Blue Water Vaccines Inc., a biopharmaceutical company focused on creating transformative vaccines solving global health challenges, has entered into an exclusive worldwide license agreement for the development of a Streptococcus Pneumoniae vaccine with St. Jude Children's Research Hospital, the nation's leading hospital dedicated to understanding, treating and curing childhood cancer and other life-threatening diseases.

11 Feb 2020

2019-nCoV: Infectious virus can be isolated from nose, throat swabs of patients with mild symptoms

Laboratory testing by Charité - Universitätsmedizin Berlin, the Bundeswehr Institute of Microbiology and Munich Clinic Schwabing has revealed that infectious virus can be isolated from nose and throat swabs even where these have been obtained from patients with mild symptoms.

6 Feb 2020

Nasal sprays cut down usage of antibiotics for individuals with chronic rhinosinusitis

Nasal saline and corticosteroid sprays are pretty standard treatment for individuals battling chronic rhinosinusitis.

17 Dec 2019

Study shows how Chlamydia bacteria enter human cells

Chlamydia are bacteria that can infect human and animal cells. Human health is particularly affected by Chlamydia pneumoniae (Cpn) and Chlamydia trachomatis.

31 Oct 2019

Only half of patients with sinus, throat, or ear infections receive first-line antibiotics

Investigators have now shown that only half of patients presenting with sinus, throat, or ear infections at different treatment centers received the recommended first-line antibiotics, well below the industry standard of 80 percent.

25 Sep 2019

Stem cells with 'dual identity' associated with loss of smell from inflammation in chronic sinusitis

In experiments with mice and human tissue samples, Johns Hopkins Medicine researchers report evidence that neuronal stem cells in the part of the nose responsible for the sense of smell transform themselves to perpetuate the long-term inflammation in chronic sinusitis.

19 Sep 2019

Australian doctors are overprescribing flu antivirals, study reveals

Australian doctors are prescribing antivirals for people with the flu who may not benefit, putting patients at risk of unnecessary side effects and potentially increasing the risk of antimicrobial resistance to these medications, researchers from the University of Adelaide have found.

8 May 2019

Outpatient healthcare providers inappropriately prescribe antibiotics to 40% of patients

Outpatient healthcare providers inappropriately prescribed antibiotics to 40 percent of patients in a major Veterans Affairs healthcare system, a higher figure than in previous studies examining outpatient antibiotic use, according to a new study appearing in the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology published by Elsevier.

17 Apr 2019

Johns Hopkins researchers find genetic cause of olfactory neuroblastoma

By sequencing the entire genomes of tumor cells from six people with a rare cancer of the nose and sinus cavity, Johns Hopkins researchers report they unexpectedly found the same genetic change¾one in a gene involved in muscle formation¾in five of the tumors.

28 Feb 2019

Unique form of chronic sinusitis found in older patients

Older patients with a diagnosis of chronic sinusitis -- a disease of the nasal cavity and paranasal sinuses that often persists over many years -- have a unique inflammatory signature that may render them less responsive to steroid treatment, according to a new study published by Vanderbilt researchers.

23 Jan 2019

MUHC's 'Dr. House' discovers new genetic disease and the gene responsible for it

A team from the Research Institute of the McGill University Health Centre led by Dr. Donald Vinh, the RI's so-called "Dr. House" because of his research into rare diseases, has discovered a new human disease and the gene responsible for it, paving the way for the proper diagnosis of patients globally and the development of new therapies.

7 Dec 2018

Pooled analysis of Intersect ENT's steroid releasing implants in patients after frontal sinus surgery to be published

Intersect ENT, Inc., a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced publication of a pooled analysis in the International Forum of Allergy & Rhinology, the official journal of the American Rhinologic Society, of the company's PROPEL Contour and PROPEL Mini steroid-releasing sinus implants showing improved outcomes of frontal sinus surgery.

16 Nov 2018

Sinusitis News and Research

Latest Sinusitis News and Research

Study identifies new allergy pathway

'Good' bacteria have a niche in our noses, study suggests

ACTG initiates clinical trial to evaluate treatment for COVID-19

Universal childhood vaccination could prevent antimicrobial resistance

Intermountain Healthcare and University of Utah Health launch two COVID-19 clinical trials

University of Utah Health, Intermountain Healthcare launch two clinical trials to treat COVID-19 patients

Novel, affordable pneumonia vaccine tested in human patients

COVID19 patients describe a loss of smell and taste

Blue Water Vaccines enters into agreement to develop Streptococcus pneumoniae vaccine with St. Jude

2019-nCoV: Infectious virus can be isolated from nose, throat swabs of patients with mild symptoms

Nasal sprays cut down usage of antibiotics for individuals with chronic rhinosinusitis

Study shows how Chlamydia bacteria enter human cells

Only half of patients with sinus, throat, or ear infections receive first-line antibiotics

Stem cells with 'dual identity' associated with loss of smell from inflammation in chronic sinusitis

Australian doctors are overprescribing flu antivirals, study reveals

Outpatient healthcare providers inappropriately prescribe antibiotics to 40% of patients

Johns Hopkins researchers find genetic cause of olfactory neuroblastoma

Unique form of chronic sinusitis found in older patients

MUHC's 'Dr. House' discovers new genetic disease and the gene responsible for it

Pooled analysis of Intersect ENT's steroid releasing implants in patients after frontal sinus surgery to be published

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Sinusitis News and Research

Latest Sinusitis News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in